Aug 6 (Reuters)-
Garna Biosciences Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2025 Jun 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 251 mln 315 mln 722 mln
(-20.4 pct) (-36.9 pct) (+13.5 pct)
Operating loss 1.05 loss 1.10 loss 2.13
Recurring loss 1.06 loss 1.09 loss 2.14
Net loss 1.06 loss 1.09 loss 2.15
EPS loss 55.29 yen loss 63.25 yen loss 112.46 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Garna Biosciences Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T